Hypoferritinemia Without Anemia Among Reproductive Age Females

Launched by AKRAM MEDICAL COMPLEX · May 25, 2024

Keywords

ClinConnect Summary

At present the commonly identified presentation is Iron Deficiency Anemia which currently affects more than 1 billion people while Hypoferritenemia without Anemia (HWA) is at least twice as common. HWA is poorly recognized by clinicians despite its high prevalence, probably because of suboptimal screening recommendations.

HWA: Patients having normal Hemoglobin of ≥12 g/dl and having below normal range ferritin level \< 30ng/ml and patients suffering from any of the following symptoms of

* Fatigue/ tiredness
* Poor work productivity
* Poor attention
* Poor memory
* Sore tongue
* Poor condi...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Reproductive age females: 18 to 45 years
• • Clinical symptoms of iron deficiency which are fatigue/ tiredness, poor work productivity, poor attention and memory loss, sore tongue, poor condition of skin, nails or hair, including hair loss, delayed skin wound healing, palpitation and restless leg syndrome
• • Normal CBC: hemoglobin level12mg/dl and above
• • Serum ferritin levels: below 30 ng/ml
• • Normal thyroid levels
• • Normal blood sugar levels
• • Willing and able to sign informed consent
• Exclusion Criteria:
• • Males
• • Post-menopausal
• • Premature menopause
• • Anemic Females: hemoglobin levels i.e. less than 12 g/dl
• • Serum ferritin level above 30 ng/ml.
• • Disturbed thyroid levels
• • Disturbed blood sugar levels
• • Pregnant
• • Lactating
• • Blood donors
• • Co-morbidities i.e., celiac disease, hemorrhoids, malignancies, hematuria, ulcers, heart failure, renal failure, chronic gastric symptoms/ gastric ulcers, chronic liver disease, disturbed thyroid levels and diabetes
• • Any medication or supplement which may impact iron metabolism.
• • History of iron or multivitamins supplementation in the last 3 months

Trial Officials